Professional services firm Huron Consulting Group (NASDAQ: HURN) met Wall Street’s revenue expectations in Q3 2026, with sales up 11.4% year on year to $491.5 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.87 billion at the midpoint. Its non-GAAP profit of $2.62 per share was 5.9% above analysts’ consensus estimates.
Is now the time to buy HURN? Find out in our full research report (it’s free for active Edge members).
Huron (HURN) Q3 2026 highlights:
- Revenue $491.5 million vs S&P analysts’ estimates of $493.2 million (11.4% year-on-year growth, in line)
- Adjusted EPS $2.62 vs S&P analysts’ estimates of $2.47 (5.9% beat)
- Adjusted EBITDA $77.34 million vs analyst estimates of $76 million (15.7% margin, 1.8% beat)
- Revenue guidance The company reconfirmed its revenue guidance for the full year of $1.87 billion at the midpoint
- Adjusted EPS guidance Management raised its full-year adjusted EPS guidance to $9.30 at the midpoint, a 1.1% increase
- Operating margin 12%, in line with the same quarter last year
- Market capitalization $2.95 billion
StockStory’s take
Huron Consulting Group's third quarter was marked by robust year-on-year revenue growth, yet the market response was notably negative. Management attributed the results to strong organic expansion in both healthcare and education, with AI-enhanced digital solutions and managed services cited as primary growth engines. CEO Mark Hussey emphasized the impact of AI, stating that over 65% of recent digital bookings involved AI-enabled projects, up from 50% a year ago. In the commercial segment, however, organic growth lagged as digital project execution faced delays and restructuring assignments normalized. Management acknowledged these trends, noting that investments in industry expertise and leadership talent are intended to bolster future momentum.
Looking ahead, Huron’s updated guidance is anchored in a strong backlog and growing demand for digital transformation, particularly in healthcare and education. Management believes that the upcoming regulatory changes in healthcare—most notably the OBBBA in 2027—will drive further demand for consulting and managed services. CFO John Kelly highlighted expectations for continued high levels of performance-based fee contracts, especially within healthcare, and stressed that investments in commercial segment leadership are expected to support above-average growth in the future. Management remains focused on productivity gains and leveraging AI and automation to expand margins and sustain top-line growth.
Key insights from management’s remarks
Management pointed to sector-specific demand and technology investments as crucial drivers of third quarter performance, with ongoing challenges in commercial digital sales and a clear focus on positioning for future growth.
- Healthcare managed services surge: The healthcare segment posted notable gains, driven by demand for managed services and AI-powered digital offerings. Management said recurring, outcomes-based contracts and the RelateCare acquisition contributed to broad-based client growth, not just a handful of large deals.
- AI-driven digital transformation: Across all segments, AI integration was a major factor in client engagements, with over 65% of recent digital bookings involving direct AI scope or significant enablement. Management described use cases ranging from operational automation to digital twins for scenario modeling.
- Education productivity boosts margins: The education segment achieved higher margins due to increased productivity per consultant and improved utilization of proprietary tools. Management emphasized that revenue growth outpaced headcount increases, reflecting efficiency initiatives.
- Commercial segment investments: Commercial revenue grew partly through the acquisition of Wilson Perumal, but organic growth was muted. Management described ongoing investments in sector expertise and leadership as proactive measures to enable above-company-average growth in 2027.
- Performance-based fee momentum: In healthcare, a higher proportion of revenue came from performance-based contracts, which typically require Huron to meet client outcomes before payment. This contributed to short-term working capital pressures but is viewed by management as a positive for long-term growth and client retention.
Drivers of future performance
Huron’s outlook is shaped by regulatory changes in healthcare, AI adoption, and continued investments in productivity and talent.
- Healthcare regulatory tailwinds: Management expects the OBBBA’s implementation in 2027, which brings new Medicaid eligibility and reimbursement rules, to increase demand for consulting and managed services as healthcare providers adapt to more complex requirements.
- Commercial growth investments: Leadership is investing in new talent and industry vertical expertise in the commercial segment, aiming to accelerate growth above the company’s average in the next year. These efforts are seen as necessary to improve both pipeline conversion and long-term market position.
- AI and productivity gains: Management intends to leverage AI and automation for both client solutions and internal operations. These technology-driven initiatives are expected to sustain high utilization rates and improve margins, particularly within education and healthcare, while also supporting scalable growth without proportionate headcount increases.
Catalysts in upcoming quarters
Looking forward, the StockStory team will be monitoring (1) how effectively Huron converts its healthcare and education pipeline into sustained revenue amid regulatory changes; (2) whether commercial segment investments translate into improved organic growth and pipeline conversion; and (3) the degree to which AI-driven product and service offerings can further boost productivity and client demand. Progress on collections from performance-based contracts and the expansion of managed services will also be key indicators of execution.
Huron currently trades at $185.75, down from $198.17 just before the earnings. Is there an opportunity in the stock? See for yourself in our full research report (it’s free).
High quality stocks for all market conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
